You know something big is up when the world’s second-largest reinsurer, Swiss Re, has its eye on the future of diabetes treatment. And when the reinsurer hosts a global four-day conference casting serious doubt on mainstream medical treatment for type 2 diabetes. In other words, speakers said at the June conference, conventional medicine keeps diabetic patients sick, fat and drug-dependent. That makes messages emanating from the conference that much more groundbreaking. Among them are that type 2 diabetes is not chronic, progressive and degenerative; it can be reversed, even put into remission. Low-carbohydrate, high-fat (LCHF) diets are safe, effective methods of reversing it without drugs or invasive bariatric (stomach) surgery. Conference speakers also slated official low-fat, high-carb dietary guidelines as contributing to global epidemics of obesity and type 2 diabetes (or "diabesity" as doctors now call the twin incidence) and need radical revision.

It doesn’t take a roc...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now